Terumo Corp
4543.T- Latest Trade
- trading higher4,432JPY
- 84
- 1.93%
- As of Jun 10 2023. Values delayed up to 15 minutes
- Today's Range
- 4,345.00 - 4,442.00
- 52 Week Range
- 3,416.00 - 4,744.00
- Previous Close
- 4,348.00
- Open
- 4,418.00
- Volume
- 3,811,700.00
- 3 Month Average Trading Volume
- 52.17
- Shares Out (Mil)
- 744.61
- Market Cap
- 3,250,924.00
- Forward P/E
- 30.42
- Dividend Yield
- 0.92
Key Statistics
1.94 mean rating - 16 analysts
- P/E Excl. Extra Items (TTM)
- 36.55
- Price To Sales (TTM)
- 3.96
- Price To Book (Quarterly)
- 2.91
- Price To Cash Flow (Per Share TTM)
- 20.37
- Total Debt/Total Equity (Quarterly)
- 20.88
- Long Term Debt/Equity (Quarterly)
- 19.87
- Return On Investment (TTM)
- 6.67
- Return On Equity (TTM)
- 5.81
2021 (millions USD)
About Terumo Corp (4543.T)
Company Information
TERUMO CORPORATION is a manufacturer of medical supplies. The Company operates in three segments. The Cardiac and Vascular Company segment is engaged in the manufacture of catheter system and cardiopulmonary system products, the import of the cardiopulmonary systems and artificial blood vessels, as well as the sale of products mainly to hospitals and clinics nationwide through agents. The Hospital Company segment is engaged in the manufacture, purchase and sale of hospital medical equipment, pharmaceuticals, peritoneal dialysis and diabetes related products, and the rental of hospital medical equipment and home medical products. The segment is also engaged in the manufacture and sale of healthcare related products. The Blood System Company segment is engaged in the manufacture and sale of blood transfusion-related products.
Address
2-44-1, HatagayaSHIBUYA-KU, TKY
151-0072
Japan
Industry
Medical Equipment & Supplies
Executive Leadership
- Toshiaki Takagi
- Chairman of the Board, Representative Director
- Shinjiro Sato
- President, Chief Executive Officer, Representative Director
- Naoki Muto
- Executive Officer, Chief Accounting & Financial Officer
- Itaru Sakaguchi
- Senior Executive Officer, Chief Operating Officer (COO) of Cardiovascular Company TIS Business, President of Subsidiary
- Kyo Nishikawa
- Managing Executive Officer, Chief Human Resource Officer, Director
- Fumihisa Hirose
- Managing Executive Officer, Chief Technology Officer, Manager of Corporate Planning
- Hitoshi Hasegawa
- Executive Officer, Chief Information Officer
- Shoji Hatano
- Senior Managing Executive Officer, Director
- Toshihiko Osada
- Senior Managing Executive Officer, President of Cardiovascular Company, President of TIS Business in Cardiovascular Company
- Hikaru Samejima
- Senior Managing Executive Officer, President of Medical Care Solutions Company
- Kazunori Hirose
- Managing Executive Officer, Chief Manufacturing Officer (CMO), Director
- Antoinette Gawin
- Managing Executive Officer, President of Blood System Company, President & Chief Executive Officer of Subsidiary
- Tsuyoshi Tomita
- Senior Executive Officer, President of Hospital Care Solutions Business in Medical Care Solutions Company
- Nishizaki Hitoshi
- Executive Officer, Chief Director of Domestic Sales
- Keiji Takeda
- Executive Officer, Director of Human Resources
- Probir Das
- Executive Officer, Chairman of Subsidiary
- Robert DeRyke
- Executive Officer, President of Cardiovascular Business in Cardiovascular Company, President and CEO of Subsidiary
- Noritsugu Fujita
- Executive Officer, President of Pharmaceutical Solutions Business, Medical Care Solutions Company
- Yagi Hiroshi
- Executive Officer, Manager of Ashitaka Factory TSI Business in Cardiovascular Company
- Norimasa Kunimoto
- Executive Officer, President of Subsidiary
- Takeshi Kuroo
- Executive Officer, Senior Vice President of Surgery in Cardiovascular Company, Manager of Heart Sheet Business Office in Cardiovascular Company
- Tomoko Manabe
- Executive Officer, Manager of Terumo Medical Pranex Center
- Masayuki Maruta
- Executive Officer, Chairman & General Manager of Subsidiary
- Miho Mizuguchi
- Executive Officer, Chief Legal Officer(CLO), Manager of Legal Affairs & Compliance Office
- Hiroshi Nagumo
- Executive Officer, Officer, President & CEO of Subsidiary
- Toshio Nakashima
- Executive Officer, Chief Quality Officer, Director of Quality Assurance
- Erik Pomp
- Executive Officer, Presideng of Neurovascular Business, Cardiovascular Company, CEO of Subsidiary
- James Rushworth
- Executive Officer, Chief Commercial Officer (CCO) of TIS Business in Cardiac & Vascular Company, President & Chief Executive Officer of Subsidiary
- Carsten Schroeder
- Executive Officer, President of Neurovascular Business, Cardiovascular Company, CEO of Subsidiary
- Kazuhisa Senshu
- Executive Officer, Chief Clinical & Regulatory Affairs Officer (CRAO) , Director of Clinical Development
- Takanori Shibazaki
- Director
- Yukiko Kuroda
- Independent Director
- Masaichi Nakamura
- Independent Director
- Hidenori Nishi
- Independent Director
- Keiya Ozawa
- Independent Director
- Soichiro Uno
- Independent Director
Latest News
- MarketsJapanese shares fall on weak tech stocks, post first weekly gain in three
Japanese shares fell on Friday, weighed down by tech stocks and caution ahead of U.S. inflation data, but posted their first weekly gain in three on easing worries over the Omicron coronavirus variant's impact on the pace of economic recovery.
- MarketsJapanese shares weighed down by tech stocks but set for weekly gain
Japanese shares fell on Friday, weighed down by tech stocks and caution ahead of U.S. inflation data, but benchmark indexes were set for their first weekly gain in three as fears around the Omicron coronavirus variant eased.
Financials
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes
Markets Performance
Official Data PartnerCommodities
| Future | Last | % Change |
|---|---|---|
| Gold | 1,960.30 | 0.17% |
| Copper | 723.65 | 0.19% |
| Brent Crude Oil | 74.79 | -- |
| CBOT Soybeans | 1,387.75 | 1.80% |
Stocks
| Index | Last | % Change |
|---|---|---|
| S&P 500 | 4,298.86 | 0.11% |
| Euro STOXX 50 | 4,289.79 | 0.18% |
| FTSE 100 | 7,562.36 | 0.49% |
| Nikkei 225 | 32,265.17 | 1.97% |
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes